Error: Could not add to watchlist. X
+ Watchlist

Ranbaxy Laboratories Ltd

RBXY:IN
Acquired
RBXY:IN was acquired by SUNP:IN
INR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (INR) (TTM)
-28.64
Market Cap (INR)
-
Shares Outstanding (m)
425.664
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.16%
% Price Change
-0.17%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Ranbaxy Laboratories Limited manufactures and distributes a wide range of pharmaceutical products. The Company makes multisource antibiotics, analgesics, anti-inflammatory drugs and anti-ulcerant/gastrointestinal drugs such as "Roscillin" (Ampicillin), "Cifran" (Ciprofloxacin) and "Sporidex" (Cephalexin).
Address
Plot 90, Sector 32
Gurgaon, 122001
India
Phone
91-12-4413-5000
Show More